ARTICLES
Quality-of-life assessment: performance status upstaged?
J Weeks
JCO Dec 1 1992: 1827–1829. [PDF]
Cancer pain: from curriculum to practice change
RK Portenoy
JCO Dec 1 1992: 1830–1832. [PDF]
	Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group
	A Coates, V Gebski, D Signorini, P Murray, D McNeil, M Byrne, and JF Forbes
	JCO Dec 1 1992: 1833–1838. [Abstract] [PDF]
	Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient
	BG Haffty, M Toth, S Flynn, D Fischer, and D Carter
	JCO Dec 1 1992: 1839–1847. [Abstract] [PDF]
	Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trial
	DC Tormey, R Gray, MD Abeloff, DL Roseman, KW Gilchrist, EJ Barylak, P Stott, and G Falkson
	JCO Dec 1 1992: 1848–1856. [Abstract] [PDF]
	Treatment of recurrent and refractory pediatric solid tumors with high- dose busulfan and cyclophosphamide followed by autologous bone marrow rescue
	ML Graham, AM Yeager, BG Leventhal, JM Wiley, CI Civin, LC Strauss, CA Hurwitz, RL Dubowy, MD Wharam, Jr, and PM Colombani
	JCO Dec 1 1992: 1857–1864. [Abstract] [PDF]
	Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle Osseuse
	G Michel, E Gluckman, D Blaise, H Esperou-Bourdeau, JP Vernant, M Kuentz, P Bordigoni, N Milpied, H Rubie, and I Thuret
	JCO Dec 1 1992: 1865–1869. [Abstract] [PDF]
	Standard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for Neuroblastoma
	B De Bernardi, M Carli, F Casale, P Corciulo, L Cordero di Montezemolo, C De Laurentis, S Bagnulo, M Brisigotti, N Marchese, and A Garaventa
	JCO Dec 1 1992: 1870–1878. [Abstract] [PDF]
	Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia
	R Wasserman, N Galili, Y Ito, JH Silber, BA Reichard, S Shane, RB Womer, B Lange, and G Rovera
	JCO Dec 1 1992: 1879–1888. [Abstract] [PDF]
	Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation
	LS Lashford, IJ Lewis, SL Fielding, MA Flower, S Meller, JT Kemshead, and D Ackery
	JCO Dec 1 1992: 1889–1896. [Abstract] [PDF]
	Plasma pharmacokinetics and pharmacodynamics of a new prodrug N-l- leucyldoxorubicin and its metabolites in a phase I clinical trial
	J de Jong, GJ Geijssen, CN Munniksma, JB Vermorken, and WJ van der Vijgh
	JCO Dec 1 1992: 1897–1906. [Abstract] [PDF]
	Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sezary syndrome
	FM Foss, DC Ihde, DL Breneman, RM Phelps, AB Fischmann, GP Schechter, I Linnoila, JC Breneman, JD Cotelingam, and BC Ghosh
	JCO Dec 1 1992: 1907–1913. [Abstract] [PDF]
	Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group study
	RM Bukowski, C Tangen, R Lee, JS Macdonald, AB Einstein, Jr, R Peterson, and TR Fleming
	JCO Dec 1 1992: 1914–1918. [Abstract] [PDF]
	A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma
	S Pyrhonen, M Hahka-Kemppinen, and T Muhonen
	JCO Dec 1 1992: 1919–1926. [Abstract] [PDF]
	Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study
	A Niiranen, S Niitamo-Korhonen, M Kouri, A Assendelft, K Mattson, and S Pyrhonen
	JCO Dec 1 1992: 1927–1932. [Abstract] [PDF]
	Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program
	L Leichman, H Silberman, CG Leichman, CP Spears, M Ray, FM Muggia, M Kiyabu, R Radin, L Laine, and S Stain
	JCO Dec 1 1992: 1933–1942. [Abstract] [PDF]
	A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients
	BU Mueller, J Skelton, DP Callender, D Marshall, J Gress, D Longo, J Norton, M Rubin, D Venzon, and PA Pizzo
	JCO Dec 1 1992: 1943–1948. [Abstract] [PDF]
	Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first- line CHOP
	LF Verdonck, AW Dekker, GC de Gast, ML van Kempen, HM Lokhorst, and HK Nieuwenhuis
	JCO Dec 1 1992: 1949–1954. [Abstract] [PDF]
	Granulocyte-macrophage colony-stimulating factor or granulocyte colony- stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients
	AM Gianni, M Bregni, S Siena, M Magni, M Di Nicola, F Lombardi, C Tarella, A Pileri, and G Bonadonna
	JCO Dec 1 1992: 1955–1962. [Abstract] [PDF]
	Clinical evaluation of MGI 209, an anesthetic, film-forming agent for relief from painful oral ulcers associated with chemotherapy
	FG LeVeque, JB Parzuchowski, GC Farinacci, SW Redding, B Rodu, JT Johnson, GA Ferretti, PD Eisenberg, and MB Zimmer
	JCO Dec 1 1992: 1963–1968. [Abstract] [PDF]
	Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single- dose regimens in the prevention of cisplatin-induced nausea and vomiting
	TM Beck, PJ Hesketh, S Madajewicz, RM Navari, K Pendergrass, EP Lester, JA Kish, WK Murphy, JD Hainsworth, and DR Gandara
	JCO Dec 1 1992: 1969–1975. [Abstract] [PDF]
	Cancer Pain Assessment and Treatment Curriculum Guidelines. The Ad Hoc Committee on Cancer Pain of the American Society of Clinical Oncology
	JCO Dec 1 1992: 1976–1982. [Abstract] [PDF]
Prerequisites for in vivo cell kinetic studies in patients
A Riccardi, M Danova, and G Ucci
JCO Dec 1 1992: 1983–1984. [PDF]
Suramin: is adaptive control necessary?
K Kobayashi, EE Vokes, K Stefansson, L Janisch, NJ Vogelzang, F Berezin, and MJ Ratain
JCO Dec 1 1992: 1984–1985. [PDF]
Suramin for prostate carcinoma
SJ Harland
JCO Dec 1 1992: 1985–1986. [PDF]
Hepatic arterial floxuridine infusion and patient survival
CG Moertel
JCO Dec 1 1992: 1986–1988. [PDF]

SPECIAL DEPARTMENTS
ERRATUM
	Pharmacokinetics and Pharmacodynamics of Medroxyprogesterone Acetate in Advanced Breast Cancer Patients
	M.C. Etienne, G. Milano, M. Frenay, N. Renee, E. Francois, A. Thyss, M. Schneider, and M. Namer
	JCO Dec 1 1992: 1988. [Abstract] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.